PatientMatch — Privacy-first clinical trial discovery

Showing 1–24 of 42 trials

Enrolling now

Nationwide

18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer

M.D. Anderson Cancer Center

Ph 1·~3yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

64Cu-LNTH-1363S Trial

Lantheus Medical Imaging

Ph 1/2·~8mo·5 sites in CA, MI, OH

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Daiichi Sankyo

Ph 2·~5yr·13 sites in CA, CT, FL +8

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Sutro Biopharma, Inc.

Ph 1·~2yr·6 sites in CO, FL, MA +2

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Dose Escalation and Dose Expansion Study of MDX2001

ModeX Therapeutics, An OPKO Health Company

Ph 1/2·~5yr·6 sites in CO, FL, MA +2

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy

University of Utah

Procedure·Ph 1·~6yr·1 site in UT

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

IDOV-Immune Trial

ViroMissile, Inc.

Ph 1·~2yr·3 sites in MO, TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

IMPROVE-Esophageal Trial

University of Pittsburgh

Lifestyle·~15mo·1 site in PA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Perspective Therapeutics

Ph 1/2·~7yr·3 sites in MO, NE, PA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

Medical College of Wisconsin

Procedure·Ph 2·~7yr·1 site in WI

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Serial MRI Scans During Radiation Therapy

Dana-Farber Cancer Institute

~11yr·2 sites in MA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

AstraZeneca

Ph 3·69 sites in AR, AZ, CA +27

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer

SOFIE

Ph 3·~2yr·10 sites in CA, FL, IN +3

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Eli Lilly and Company

Ph 1·~3yr·13 sites in CA, CO, FL +7

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Tanabe Pharma America, Inc.

Ph 1/2·~3yr·4 sites in CA, MI, OH +1

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

EQUITY GI Trial

Case Comprehensive Cancer Center

~1.5yr·1 site in OH

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)

Cedars-Sinai Medical Center

Ph 4·~13mo·1 site in CA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Neonc Technologies, Inc.

Ph 1/2·~4yr·6 sites in CA, TN, TX +1

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

CYTALUX (Pafolacianine) Trial

John Waters

Ph 2·~2yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus

Northwestern University

Device·~5yr·4 sites in CA, CO, IL +1

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Jazz Pharmaceuticals

Ph 2·~3yr·16 sites in AZ, CO, FL +6

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Memorial Sloan Kettering Cancer Center

Ph 2·~4yr·10 sites in MA, NJ, NY +2

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Phrontline Biopharma

Ph 1·~2yr·3 sites in FL, TN, TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors

Baylor College of Medicine

Ph 1·~18yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify